Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 31 M25 M27 M41 M28 M29 M 125 M Research & development —————— — Operating income 285 M277 M101 M192 M319 M293 M 905 M Non-Operating Income, Total 4 M22 M122 M0242 M-1 M 363 M Interest expense, net of interest capitalized 57 M58 M60 M60 M59 M58 M 237 M Non-Operating Income, excl. Interest Expenses -53 M-36 M62 M-60 M183 M-59 M 126 M Unusual income/expense —————— — Pretax income 250 M252 M172 M144 M518 M259 M 1.09 B Equity in earnings 10 M4 M2 M2 M4 M7 M 15 M Taxes -1 M27 M9 M7 M17 M18 M 51 M Non-controlling/minority interest 3 M4 M2 M2 M7 M4 M 15 M After tax other income/expense —————— — Net income before discontinued operations 248 M221 M161 M135 M494 M237 M 1.03 B Discontinued operations —————— — Net income 248 M221 M161 M135 M494 M237 M 1.03 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 248 M221 M161 M135 M494 M237 M 1.03 B Basic earnings per share (Basic EPS) 0.350.320.230.210.720.35 1.51 Diluted earnings per share (Diluted EPS) 0.350.320.230.20.720.35 1.5 Average basic shares outstanding 697.8 M692.5 M687.5 M691.4 M687.5 M684.9 M — Diluted shares outstanding 698.3 M693.9 M689.5 M694.1 M689.3 M687 M — EBITDA 288 M280 M104 M194 M322 M296 M 916 M EBIT 285 M277 M101 M192 M319 M293 M 905 M Cost of revenue 111 M107 M103 M—103 M94 M — Other cost of goods sold 111 M107 M103 M—103 M94 M — Depreciation & amortization (cash flow) 3 M3 M3 M2 M3 M3 M 11 M